This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Parathyroid Surgery Experts No Longer Performing One-Side Parathyroid Operation For Hyperparathyroidism

TAMPA, Fla., March 28, 2012 /PRNewswire/ -- Dr James Norman, MD and his partners at the Norman Parathyroid Center have published a landmark study in this week's Journal of the American College of Surgeons describing how the operation they developed and advocated for more than 19 years has significantly poorer long-term outcomes. The unilateral or "one-side" parathyroid surgical procedure to remove parathyroid tumors from patients suffering from hyperparathyroidism is a dramatic change from the large neck operation that it replaced. Dr Norman and his partners have published many articles touting the benefits of the smaller, one-side operation, a procedure that has become the standard operation world-wide. Long-term followup, however, shows that many patients having a one-side operation will need another operation some years later to remove a second tumor.

"We changed parathyroid surgery forever in the mid 1990's by developing and advocating the use of technology to allow one-side neck operations to remove parathyroid tumors," said Norman. "We have performed over 17,500 parathyroid operations and unfortunately, quite a few patients who we believed were cured after a one-side operation began showing up with another parathyroid tumor between 3 and 15 years later. They obviously had a second smaller tumor that we did not see. In contrast, those patients in whom we examined all four parathyroid glands had a second tumor removed 20% of the time and their long-term cure rates remain near 100%."

"We began noticing big differences in cure rates about 6 years ago and thus began our avoidance of one-side parathyroid surgery," stated Dr Douglas Politz, a co-author. "Fortunately for the patients, the new mini-parathyroid operation to look at all 4 glands (both sides) is actually smaller and faster than the one-side operation we developed 18 years ago using techniques we are teaching with videos online."

"This is a very significant change in surgical practice," stated Dr Lee Metchick, an endocrinologist in Central Florida. "If one parathyroid tumor is removed and a smaller, second tumor remains, the patient doesn't achieve the full benefits of the operation." 

The study was presented at the 2011 meeting of the American College of Surgeons and is published in this month's issue of their primary Journal: Norman J, Lopez J, Politz D. Abandoning Unilateral Parathyroidectomy: Why We Reversed Our Position After 15,000 Parathyroid Operations.  Journal  American College of Surgeons. 2012 Mar;214(3):260-9

About Norman Parathyroid Center.  Located in Tampa, Florida, The Norman Parathyroid Center is the world's leading facility for the diagnosis and treatment of diseases of the parathyroid glands and hyperparathyroidism. is recognized as the leading authority on hyperparathyroidism, an illness caused by parathyroid tumors located in the neck which affect one in 1000 people causing high blood calcium, osteoporosis, chronic fatigue, depression, and kidney stones, among other conditions.

Media Contact: Callie Williford, 813-972-0000

SOURCE Norman Parathyroid Center

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 0.00%
FB $117.81 0.00%
GOOG $701.43 0.00%
TSLA $211.53 0.00%
YHOO $36.94 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs